Top

Gepubliceerd in:

01-12-2012

Correlates of hazardous drinking among Veterans with and without hepatitis C

Auteurs: Megan Oser, Michael Cucciare, John McKellar, Kenneth Weingardt

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 6/2012

Abstract

Hazardous drinking is a major barrier to antiviral treatment eligibility among hepatitis C (HCV) patients. We evaluated differences in substance-related coping, drinking-related consequences, and importance and confidence in ability to change alcohol use among hazardous drinkers with and without HCV (N = 554; 93.5% male). We examined group differences between HCV+ patients (n = 43) and their negative HCV counterparts (n = 511). Results indicate a higher percentage of HCV+ patients report using substances to cope with possible symptoms of PTSD (P < .05) and depression (P < .01), and endorse more lifetime drinking-related negative consequences than HCV patients (P < .01). Furthermore, HCV+ patients place greater importance on changing alcohol use (P < .01) but report less confidence in their ability to change (P < .01). Use of brief assessment and feedback with skills-based interventions to decrease alcohol use may be well-received by HCV+ patients.

vorige artikel Self-focus and social evaluative threat increase salivary cortisol responses to acute stress in men

volgende artikel Executive function and latent classes of childhood obesity risk

Anand, B., Currie, S., Dieperink, E., Bini, E., Shen, H., Ho, S., et al. (2006). Alcohol use and treatment of hepatitis C virus: Results of a national multicenter study. Gastroenterology, 130, 1607–1616.PubMedCrossRef

Babor, T. F., & Grant, M. (1989). From clinical research to secondary prevention: international collaboration in the development of the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Research & Health, 13, 371–374.

Baliunas, D. O., Taylor, B. J., Irving, H., Roerecke, M., Patra, J., Mohapatra, S., et al. (2009). Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care, 32(11), 2123–2132.PubMedCrossRef

Bini, E., Brau, N., Currie, S., Shen, H., Anand, B. S., Hu, K. Q., et al. (2005). Prospective multicenter study of eligibility for antiviral therapy about 4,084 U.S. Veterans with chronic hepatitis C virus infection. American Journal of Gastroenterology, 100, 1772–1779.PubMedCrossRef

Bradley, K. A., Bush, K. R., Epler, A. J., Dobie, D., Davis, T., Sporleder, J., et al. (2003). Two brief alcohol-screening tests from the Alcohol Use Disorders Identification Test (AUDIT). Archives of Internal Medicine, 163, 821–829.PubMedCrossRef

Bradley, K., Williams, E. C., Achtmeyer, C. E., Volpp, B., Collins, B. J., & Kivlahan, D. (2006). Implementation of evidence-based alcohol screening in the Veterans Health Administration. American Journal of Managed Care, 12(10), 597–606.PubMed

Butler, L. H., & Correia, C. J. (2009). Brief alcohol intervention with college student drinkers: Face-to-face versus computerized feedback. Psychology of Addictive Behavior, 23(1), 163–167.CrossRef

Butt, A., Justice, A., Skanderson, M., Rigsby, M., Good, C., & Kwoh, C. K. (2007). Rate and predictors of treatment prescription for hepatitis C. Gut, 56, 385–389.PubMedCrossRef

Center for Quality Management in Public Health. (2010). The state of care for Veterans with chronic hepatitis C. Palo Alto, California: U.S. Department of Veteran Affairs, Public Health Strategic Health Care Group, Center for Quality Management in Public Health, 2010.

Centers for Disease Control and Prevention. (2009). Hepatitis C information for professionals. Available at http://www.cdc.gov/hepatitis/HCV/index.htm. Accessed 10 Oct 2009.

Chen, C., Yoon, Y., Yi, H., & Lucas, D. (2007). Alcohol and hepatitis C mortality among males and females in the United States: A life table analysis. Alcoholism, Clinical and Experimental Research, 31(2), 285–292.PubMedCrossRef

Cheung, R., Cunnigham, B., & Cooper, A. (2006). Effectiveness of a screening program for hepatitis C. Digestive Diseases and Sciences, 51(5), 976–981.PubMedCrossRef

Choo, Q., Kuo, G., Weiner, A., Overby, L., Bradley, D., & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244(4902), 359–362.PubMedCrossRef

Cucciare, M., Darrow, M., & Weingardt, K. (2010). Characterizing binge drinking among U.S. military Veterans receiving a brief alcohol intervention. Addictive Behaviors, 36(4), 362–367.PubMedCrossRef

Dieperink, E., Ho, S., Heit, S., Durfee, J., Thuras, P., & Willenbring, M. (2010). Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinic. Psychosomatics, 51, 149–156.PubMed

El-Serag, H., Kunik, M., Richardson, P., & Rabeneck, L. (2002). Psychiatric disorders among Veterans with hepatitis C infection. Gastroenterology, 123, 476–482.PubMedCrossRef

Feinn, R., Tennen, H., & Kranzler, H. (2003). Psychometric properties of the short index of problems as a measure of recent alcohol-related problems. Alcoholism, Clinical and Experimental Research, 27(9), 436–441.CrossRef

Fireman, M., Indest, D., Blackwell, A., Whitehead, A., & Hauser, P. (2005). Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): The importance of routine mental health screening as a component of a comanagement model of care. Clinical Infectious Disease, 40(Suppl 5), S286–S291.CrossRef

Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830–842.PubMedCrossRef

Hutchinson, S., Bird, S., & Goldberg, D. (2005). Influence of alcohol on the progression of hepatitis C virus infection: A meta-analysis. Clinical Gastroenterology & Hepatology, 3, 1150–1159.CrossRef

Keppel, G., & Wickens, T. D. (2004). Design and analysis: A Researcher’s handbook (4th ed.). NJ: Prentice Hall.

Lehman, C., & Cheung, R. (2002). Depression, anxiety, post-traumatic stress, and alcohol-related problems among Veterans with chronic hepatitis C. American Journal of Gasteroenterology, 97, 2640–2646.CrossRef

Leiber, C. (2003). Hepatitis C and alcohol. Journal of Clinical Gastroenterology, 36(2), 100–102.CrossRef

Management of Hepatitis C. (2002). NIH Consensus Science Statements, 19(3), 1–46.

Monto, A., Patel, K., Bostrum, A., Pianko, S., Pockros, P., McHutchinson, J. G., et al. (2004). Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology, 39, 826–834.PubMedCrossRef

Morril, J., Shrestha, M. C. H. E. S., & Grant, R. (2005). Barriers to the treatment of hepatitis C Patient, provider, and system factors. Journal of General Internal Medicine, 20(8), 754–758.CrossRef

Muir, A., & Provenzale, D. (2002). A descriptive evaluation of eligibility for therapy among Veterans with chronic hepatitis C infection. Journal of Clinical Gastroenterology, 34(3), 268–271.PubMedCrossRef

Nguyen, T., Jamal, M., & Morgan, T. (2007). Alcohol abuse and chronic hepatitis C. Current Hepatitis Reports, 6, 119–124.CrossRef

Nguyen, H., Miller, A., Dieperink, E., Willenbring, M., Tetrick, L., Durfee, J., et al. (2002). Spectrum of disease in U.S. Veteran patients with hepatitis C. American Journal of Gastroenterology, 97(7), 1813–1820.PubMedCrossRef

Peters, M., & Terrault, N. (2002). Alcohol and hepatitis C. Hepatology, 36, S220–S225.PubMedCrossRef

Rehm, J., Mathers, C., Popva, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Series: Alcohol an global health. Lancet, 373, 2223–2233.PubMedCrossRef

Rifai, M., Moles, J., Lehman, L., & Van der Linden, B. (2006). Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders. Psychosomatics, 47(2), 112–121.PubMedCrossRef

Squires, D. D., & Hester, R. K. (2004). Using technical innovations in clinical practice: The drinker’s check-up software program. Journal of Clinical Psychology, 60, 159–169.PubMedCrossRef

Szabo, G. (2007). Moderate drinking, inflammation, and liver disease. Annals of Epidemiology, 17(Suppl 5), S49–S54.CrossRef

Williams, J., Herman-Stahl, M., Calvin, S. L., Pemberton, M., & Bradshaw, M. (2009). Mediating mechanisms of military web-based alcohol intervention. Drug and Alcohol Dependence, 100, 248–257.PubMedCrossRef

Wise, M., Bialek, S., Finelli, L., Bell, B., & Sorvillo, F. (2008). Changing trends in hepatitis C-related mortality in the United States, 1995–2004. Hepatology, 47, 1–8.

Wong, J., McQuillan, G., McHutchinson, J., & Poynard, T. (2000). Estimating future hepatitis C morbidity, mortality, and costs in the United States. American Journal of Public Health, 90(10), 1562–1569.PubMedCrossRef

Woolard, R., Kenna, G., Longabaugh, R., Karolczuk, K., Nirenberg, T., Minugh, A., et al. (2004). Alcohol assessment validity and reliability of (SIP-ER) short index of problems. [Abstract]. Academic Emergency Medicine, 11(5), 546.

Titel: Correlates of hazardous drinking among Veterans with and without hepatitis C
Auteurs: Megan Oser
Michael Cucciare
John McKellar
Kenneth Weingardt
Publicatiedatum: 01-12-2012
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 6/2012
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-011-9394-9

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2012

Erratum to: Choice and placebo expectation effects in the context of pain analgesia

Who benefits from psychosocial interventions in oncology? A systematic review of psychological moderators of treatment outcome

Default policies and parents’ consent for school-located HPV vaccination

Executive function and latent classes of childhood obesity risk

Time perspective and weight management behaviors in newly diagnosed Type 2 diabetes: a mediational analysis

Impulsivity-related traits are associated with higher white blood cell counts